Tylenol Mess Gets Worse as Feds Probe

There have been numerous horrific findings in the Tylenol probe. We knew Tylenol was recalling several brands of their infant and child medications but now, as the probe deepens; more allegations of impropriety are emerging.

First, there were allegations of bacterial contamination in some of the equipment used to transport raw materials to the Tylenol plant at Fort Washington. The bacteria was identified as B. cepacia. While the finished products tested negative for the bacteria, the issue is still of concern to consumers.

Then, there were allegations of bad manufacturing processes. Several employees at the plant were not trained in proper manufacturing processes. The manufacturing plants also contained large amounts of dust and debris.

But here's the most shocking allegation: There were allegedly improper controls in place to oversee the manufacturing process for several batches of infant's Tylenol. As a result, there were many batches of Tylenol that were too potent or too strong.

Now, that's the scariest detail to emerge from the ongoing probe. While there have been no reported injuries from the current findings that only refers to reported injuries.

Finally, there were several reported complaints of foreign materials and dark specks in the medication. The makers of Tylenol allegedly failed to follow up on these consumer concerns.

Pennsylvania personal injury attorneys are not strangers to pharmaceutical lawsuits. But as more details emerge, so will details on the liability of Tylenol makers, Johnson & Johnson.

Related Resources

• Feds Ask $520M from AstraZeneca for its Antipsychotic Drug, Seroquel (FindLaw's Philadelphia Personal Injury Law Blog)
• FDA Warning on Avandia Threatens Pa Pharm Company (FindLaw's Philadelphia Personal Injury Law Blog)
• Find a PA Personal Injury Lawyer (FindLaw)